Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11216421 | 0.98 | TSHR (0.57) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL9794217 | 0.98 | TSHR (0.57) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL380537 | 0.98 | TSHR (0.57) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL381203 | 0.92 | LMNA (0.50) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL18879234 | 0.91 | LMNA (0.46) | LMNATSHRNFKB1PMP22AKR1B1 | |
| Adipic Acid SCHEMBL27574535 | 0.86 | GPR84 (0.52) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL28631627 | 0.84 | CAMK2A (0.48) | LMNATSHRNFKB1PMP22AKR1B1 | |
| SCHEMBL29114063 | 0.82 | MAPT (0.45) | LMNATSHRNFKB1PMP22AKR1B1 | |
| Butyric Acid SCHEMBL9343652 | 0.82 | FFAR3 (0.54) | TSHRAKR1B1GPR84PPARGPPARD | |
| SCHEMBL1908887 | 0.82 | LMNA (0.58) | LMNATSHRNFKB1PMP22AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3793973-B1 | PROCESS FOR PRODUCING AN INTRAMOLECULAR DIESTER OF A HYDROXYCARBOXYLIC ACID AND PROCESS FOR PRODUCING A POLYHYDROXYCARBOXYLIC ACID. | FRAUNHOFER GES FORSCHUNG (DE) | 2022-12-28 | — | — | EP | claimed |
| EP-3793973-A1 | PROCESS FOR PRODUCING AN INTRAMOLECULAR DIESTER OF A HYDROXYCARBOXYLIC ACID AND PROCESS FOR PRODUCING A POLYHYDROXYCARBOXYLIC ACID. | FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. (DE) | 2021-03-24 | — | — | EP | claimed |
| WO-2009127009-A1 | CONDENSATION POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | claimed |
| US-4945180-A | Process for the preparation of E-2-propyl-2-pentenoic acid and physiologically compatible salts thereof | DESITIN ARZNEIMITTEL GMBH (DE) | 1990-07-31 | — | — | US | claimed |
| EP-3793973-B1 | PROCESS FOR PRODUCING AN INTRAMOLECULAR DIESTER OF A HYDROXYCARBOXYLIC ACID AND PROCESS FOR PRODUCING A POLYHYDROXYCARBOXYLIC ACID. | FRAUNHOFER GES FORSCHUNG (DE) | 2022-12-28 | — | — | EP | disclosed |
| US-20210139390-A1 | PRODUCTION METHOD OF ORGANIC COMPOUND | UNITIKA LTD. (JP) | 2021-05-13 | — | — | US | disclosed |
| EP-3819283-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | Unitika Ltd. (JP) | 2021-05-12 | — | — | EP | disclosed |
| EP-3793973-A1 | PROCESS FOR PRODUCING AN INTRAMOLECULAR DIESTER OF A HYDROXYCARBOXYLIC ACID AND PROCESS FOR PRODUCING A POLYHYDROXYCARBOXYLIC ACID. | FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. (DE) | 2021-03-24 | — | — | EP | disclosed |
| CN-112384489-A | Method for producing organic compound | 尤尼吉可株式会社 | 2021-02-19 | — | — | CN | disclosed |
| US-10752690-B2 | Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses | REGENERON PHARMACEUTICALS, INC. (US) | 2020-08-25 | — | — | US | disclosed |
| US-20180312597-A1 | Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses | REGENERON PHARMACEUTICALS, INC. | 2018-11-01 | — | — | US | disclosed |
| EP-2460848-B1 | FILLER FOR USE IN RUBBER AND RUBBER COMPOSITION | OSAKA SODA CO LTD (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-5512653-A | Lactic acid containing hydroxycarboxylic acid for the preparation of polhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-04-30 | — | — | US | disclosed |
| EP-0707024-A2 | Purification process of polyhydroxycarboxylic acids | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-04-17 | — | — | EP | disclosed |
| US-5444143-A | Preparation process of polyhydroxycarboxylic acid | MITSUI TOATSU CHEMICALS, INC. (JP) | 1995-08-22 | — | — | US | disclosed |
| US-5440008-A | Condensation polymerization of hydroxycarboxylic acids in vertical reactor with ribbon stirrer, having flow pattern along walls in opposite direction to flow along axis of stirrer | MITSUI TOATSU CHEMICALS, INC. (JP) | 1995-08-08 | — | — | US | disclosed |
| US-5386004-A | Contacting with acid substance in presence of organic solvent | MITSUI TOATSU CHEMICALS, INC. (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0603889-A2 | Process for the preparation of lactic acid polyesters | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-06-29 | — | — | EP | disclosed |
| EP-0591978-A2 | Polyhydroxycarboxylic acid and purification process thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-04-13 | — | — | EP | disclosed |
| US-4945180-A | Process for the preparation of E-2-propyl-2-pentenoic acid and physiologically compatible salts thereof | DESITIN ARZNEIMITTEL GMBH (DE) | 1990-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180312597-A1 | Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses | CD22, CD2, CD47 | LMNA 3679/4885TSHR 2388/4885NFKB1 1791/4885 |
| US-10752690-B2 | Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses | CD22, CD2, CD47 | LMNA 3679/4885TSHR 2388/4885NFKB1 1791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.